BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9841815)

  • 1. Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients.
    Déchanet J; Merville P; Bergé F; Bone-Mane G; Taupin JL; Michel P; Joly P; Bonneville M; Potaux L; Moreau JF
    J Infect Dis; 1999 Jan; 179(1):1-8. PubMed ID: 9841815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role.
    Lafarge X; Merville P; Cazin MC; Bergé F; Potaux L; Moreau JF; Déchanet-Merville J
    J Infect Dis; 2001 Sep; 184(5):533-41. PubMed ID: 11494158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipients.
    Couzi L; Pitard V; Netzer S; Garrigue I; Lafon ME; Moreau JF; Taupin JL; Merville P; Déchanet-Merville J
    J Infect Dis; 2009 Nov; 200(9):1415-24. PubMed ID: 19780672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.
    Halary F; Pitard V; Dlubek D; Krzysiek R; de la Salle H; Merville P; Dromer C; Emilie D; Moreau JF; Déchanet-Merville J
    J Exp Med; 2005 May; 201(10):1567-78. PubMed ID: 15897274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of gammadelta T cells in the human immune response to cytomegalovirus.
    Déchanet J; Merville P; Lim A; Retière C; Pitard V; Lafarge X; Michelson S; Méric C; Hallet MM; Kourilsky P; Potaux L; Bonneville M; Moreau JF
    J Clin Invest; 1999 May; 103(10):1437-49. PubMed ID: 10330426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection in kidney allograft recipients is followed by a prolonged expansion of gammadelta T lymphocytes.
    Merville P; Déchanet J; Bergé F; Bone-Mane G; Taupin J; Michel P; Joly P; Bonneville M; Potaux L; Moreau J
    Transplant Proc; 2000 Mar; 32(2):357-9. PubMed ID: 10715438
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
    Couzi L; Thiébaut R; Carron JC; Moreau JF; Merville P; Taupin JL
    Transplantation; 2008 Oct; 86(8):1060-7. PubMed ID: 18946343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus infection in cardiac transplant recipients associated with chronic T cell subset ratio inversion with expansion of a Leu-7+ TS-C+ subset.
    Maher P; O'Toole CM; Wreghitt TG; Spiegelhalter DJ; English TA
    Clin Exp Immunol; 1985 Dec; 62(3):515-24. PubMed ID: 3002689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential impact of age and cytomegalovirus infection on the γδ T cell compartment.
    Roux A; Mourin G; Larsen M; Fastenackels S; Urrutia A; Gorochov G; Autran B; Donner C; Sidi D; Sibony-Prat J; Marchant A; Stern M; Sauce D; Appay V
    J Immunol; 2013 Aug; 191(3):1300-6. PubMed ID: 23817410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD3 bright lymphocyte population reveal gammadelta T cells.
    Lambert C; Genin C
    Cytometry B Clin Cytom; 2004 Sep; 61(1):45-53. PubMed ID: 15351982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient.
    Benz C; Holz G; Michel D; Awerkiew S; Dries V; Stippel D; Goeser T; Busch DH
    Transplantation; 2003 Mar; 75(5):724-7. PubMed ID: 12640316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial flow cytometric analysis of T-cell surface markers can be useful in differential diagnosis of renal allograft dysfunction.
    Beik AI; Morris AG; Higgins RM; Lam FT
    Clin Transplant; 1998 Feb; 12(1):24-9. PubMed ID: 9541419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal distribution of gammadelta T lymphocytes in Graves' disease and insulin-dependent diabetes type 1.
    Kretowski A; Myśliwiec J; Kinalska I
    Arch Immunol Ther Exp (Warsz); 2000; 48(1):39-42. PubMed ID: 10722230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection from cancer in kidney transplant patients by gammadelta T cells: role of CMV infection?
    Söderberg-Nauclér C
    J Am Soc Nephrol; 2010 Jan; 21(1):11-3. PubMed ID: 20007750
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of γδ T cell subsets in organ transplantation.
    Puig-Pey I; Bohne F; Benítez C; López M; Martínez-Llordella M; Oppenheimer F; Lozano JJ; González-Abraldes J; Tisone G; Rimola A; Sánchez-Fueyo A
    Transpl Int; 2010 Oct; 23(10):1045-55. PubMed ID: 20477999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
    Robak E; Błoński JZ; Bartkowiak J; Niewiadomska H; Sysa-Jedrzejowska A; Robak T
    Mediators Inflamm; 1999; 8(6):305-12. PubMed ID: 10815619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel gammadelta T-cell subsets following bacterial infection in the absence of Vgamma1+ T cells: homeostatic control of gammadelta T-cell responses to pathogen infection by Vgamma1+ T cells.
    Newton DJ; Andrew EM; Dalton JE; Mears R; Carding SR
    Infect Immun; 2006 Feb; 74(2):1097-105. PubMed ID: 16428757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.